Investor Hub
Novavax, Inc. is a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases.
Form | Description | Date | Format |
---|---|---|---|
S-3 | Simplified registration form | Dec 30, 2016 | ![]() ![]() ![]() ![]() |
S-8 | Securities offered to employees pursuant to employee benefit plans | Aug 10, 2016 | ![]() ![]() ![]() ![]() |
![]() |
Sign up for notifications from Novavax including upcoming events, webcasts, research updates, daily stock closings, SEC filings, and more.
![]() |
Shareholders seeking information can contact investor relations at (240) 268-2022 or email us at ir@novavax.com
Novavax corporate policy prohibits any employees, other than designated spokespersons, from communicating with its investors.